Article Details
Retrieved on: 2022-08-20 08:28:48
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
The drugs, Regeneron's Inmazeb (REGN-EB3) and Ridgeback Bio's Ebanga (mAb114) – use laboratory-made monoclonal antibodies that mimic natural ...
Article found on: www.sabcnews.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here